@SylvanBacaLab

GU oncologist and computational epigenomics enthusiast at @DanaFarber, Assistant Professor @harvardmed

Joined June 2022
We're #hiring a computational #postdoc! PhD in computer science or other quantitative field? Join our mission: push the boundaries of precision #oncology with computational #epigenomics and #AI. careers.dana-farber.org/job/… Please RT!
3
24
1
57
14,915
Great collaborating with Ning Shen, @zezhangzzz, and @keegankorthauer on this new paper in @CommsBio! It provides a robust new framework for deconvolving cell type-associated DNA methylation signatures from (cell-free)MeDIP-seq data: nature.com/articles/s42003-0…
3
9
705
Hard to believe that @RazaneHChehade is moving on after a productive postdoc fellowship in the lab. Best of luck on your next steps - @PittPediatrics is very fortunate to have you, and I can't wait to see what you accomplish next!
2
6
40
3,625
Proud to see one of my first mentors, Dr. Mary-Ellen Taplin, expanding options for patients with high-risk localized prostate cancer. Congrats to the PROTEUS team on this practice-changing trial! @ASCO @DanaFarber @DanaFarber_GU
1
8
352
A pleasure working with David Lee and @KimmieNgMD on this perspective: nature.com/articles/s41591-0…. Neat approach in the corresponding paper: Using DNA methylation signatures of environmental exposures to investigate what's driving the alarming rise in early-onset colorectal cancer.
1
3
1
23
4,895
Congratulations @zezhangzzz on your scholar-in-training award at @AACR! I'm thrilled to watch you and the team take cancer diagnostics in new directions and improve patient care.
Great honor to have our work recognized by the prestigious @AACR. Kudos to the team @SylvanBacaLab! l1nq.com/i39gjjg
1
7
1,085
Our latest collaboration with #MattFreedman and @Oser_Lab on resistance to tarlatamab: biorxiv.org/content/10.64898…. An exciting framework for studying cancer resistance: observations from patients using epigenomic #LiquidBiopsy -> functional validation in mouse models.
8
2
37
7,713
Looking forward to this summit @broadinstitute - great speaker lineup!
Thrilled to host the inaugural Head and Neck Cancer Liquid Biopsy Summit July 17th, 2026, @broadinstitute in Cambridge MA See the outstanding speaker lineup on the meeting website: eventleaf.com/e/HeadandNeckC… Registration is free and open to all Additional details 👇👇👇
1
3
789
Great opportunity in a fantastic lab!
📣 We’re hiring a computational genomics postdoc! 📣 Our lab at @DanaFarber is looking for a postdoctoral fellow — details👇
3
567
Great review on determinants and consequences of nucleosome spacing - very cool what you can learn from such a "simple" feature! @TeifLab
Nucleosome aficionados! Our new review "Nucleosome spacing across cell types, diseases, and ages" is out in NAR: academic.oup.com/nar/article… A huge effort to pull together what we’ve learned about nucleosome spacing in many systems. Enjoy! #nucleosomics #nucleosome #chromatin #cfDNA
9
635
Thanks for highlighting this great work by @RashadNawfal and team on blood-based readouts of DLL3 expression in cancer, @DrChoueiri!
Amazing work out of @SylvanBacaLab by our very own raising star @RashadNawfal Plasma cfChIP-seq (H3K4me3) predicted DLL3 expression in NEPC. Higher promoter signal in NEPC tumors distinguishing DLL3+ vs DLL3– Potential blood-based approach to guide DLL3-targeted therapy selection. #GU26 #ProstateCancer #NEPC @OncoAlert
2
12
1,463
Thrilled to share the latest from @gungulati and team in collab with #MattFreedman. #LiquidBiopsy can reveal gene expression in cancer by integrating circulating histone mods and cfDNA fragmentation patterns. Excited to see how this expands the reach of precision oncology!
We infer earthquakes from distant vibrations and stars from photons emitted light-years away. Can we reconstruct a patient’s tumor biology from the signals it sheds into blood? Introducing APEX (Associating Plasma Epigenomics with eXpression), our framework for inferring cancer expression from plasma. Preprint: biorxiv.org/content/10.64898… @biorxivpreprint @DanaFarber @DrChoueiri @SylvanBacaLab #FreedmanLab
7
28
4,791
Thrilled to share this collaboration with #MattFreedman and @DrChoueiri led by @sarahaboulaiwi @adib_elio, and @WinstonCheung5. Cancer epigenomes from patients have a lot to teach us about how cancer develops, from germline risk to metastasis. #TranslationalEpigenomics
Very excited our paper is online! @adib_elio @WinstonCheung5 @SylvanBacaLab @DrChoueiri #MattFreedman. sciencedirect.com/science/ar… We profile chromatin and transcription across normal kidney →primary ccRCC→metastasis to define what changes (and what persists) during progression 1/
3
25
2,779
Great collaboration with @sriviswanathan on epigenomic liquid biopsy in translocation RCC, led by @SimonGarinet and @KarlSemaan. A nice framework for diagnosing and monitoring translocation-driven cancers that have few genomic alterations.
Our latest paper is now out in @jclinicalinvest! 🎉Huge congrats to superstars🌟 @simongarinet & @karlsemaan on this study with @sylvanbacalab #FreedmanLab @drchoueiri. [1]
1
4
1
15
1,599
Excited to share some of our lab's work on epigenomic liquid biopsy for precision oncology tomorrow at the DFCI Seminars in Oncology series tomorrow!
2
3
1
23
5,403
It's a privilege to work with such a compassionate and talented group of genitourinary oncologists (plus one GI oncologist, if you can spot him @gungulati !)
1
2
26
1,895
Great tweetorial on the next chapter in precision oncology by @gungulati
Are liquid biopsy tools that capture gene expression the future of precision oncology? We tackle this question and share our vision for Precision Oncology 2.0 in @JCO_ASCO: ascopubs.org/doi/10.1200/JCO… with @DrChoueiri , #MattFreedman, @SylvanBacaLab at @DanaFarber .
2
392
Thrilled to share @gungulati's perspective piece in @JCO_ASCO describing how expression-based liquid biopsy will help guide a new wave of cancer treatments.
JUST IN: Congrats to our own @gungulati @SylvanBacaLab #Mattfreedman @DanaFarber + @DanaFarber_GU New commentary published in @JCO_ASCO @ASCO : From mutations to expression=> Precision Oncology 2.0 reveals that expression-based liquid biopsy can guide therapy selection, switching and resistance monitoring Exciting for 2026 and beyond! ascopubs.org/doi/pdf/10.1200…
1
10
810
Excited to share the lab's latest from @zezhangzzz and team: biorxiv.org/content/10.64898…. SNAP is a #nextflow-based pipeline for emerging #LiquidBiopsy datatypes including cfChIP-seq. It fills a need for analysis methods tailored to immunoprecipitation-based cfDNA profiling.
2
4
1
14
1,871
Very nice POC for detecting irAEs using methylation profiling of cfDNA: nejm.org/doi/full/10.1056/NE…. Will be great to see how this looks in larger cohorts and consider how it might guide IO. Much to learn still from non-tumor-derived cfDNA in oncology!
2
1
6
630
Looking forward to a great AACR Conference on Prostate Cancer in January!
Burcu Darst, Sylvan Baca, Jeremie Calais, and @RaqPerezLopez will discuss "Recent Advances in Risk, Detection, and Diagnosis" in a plenary at the AACR Conference on Prostate Cancer (January 20-22; Boston). brnw.ch/21wXDxt #AACRprostate26 @SylvanBacaLab @CalaisJeremie
1
8
523